Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure

Juan C. Duque, Marwan Tabbara, Laisel Martinez, Jose Cardona, Roberto I Vazquez-Padron, Loay Salman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The arteriovenous fistula (AVF) is the preferred hemodialysis access type because it has better patency rates and fewer complications than other access types. However, primary failure remains a common problem impeding AVF maturation and adding to patients’ morbidity and mortality. Juxta-anastomotic (or inflow) stenosis is the most common reason leading to primary failure, and percutaneous transluminal angioplasty continues to be the gold-standard treatment with excellent success rates. Intimal hyperplasia (IH) has been traditionally blamed as the main pathophysiologic culprit, but new evidence raises doubts regarding the contribution of IH alone to primary failure. We report a 64-year-old man with a 2-stage brachiobasilic AVF that was complicated by failure 4 months after creation. An angiogram showed multiple juxta-anastomotic and midfistula stenotic lesions. Percutaneous transluminal angioplasty was successful in assisting maturation and subsequently cannulating the AVF for hemodialysis treatment. We failed to identify the underlying cause of stenosis because biopsy specimens from fistula tissue obtained at the time of transposition revealed no occlusive IH. This case emphasizes the need for additional research on factors contributing to AVF failure besides IH and highlights the need for more therapeutic options to reduce AVF failure rate.

Original languageEnglish (US)
Pages (from-to)147-151
Number of pages5
JournalAmerican Journal of Kidney Diseases
Volume69
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Arteriovenous Fistula
Angioplasty
Tunica Intima
Dialysis
Hyperplasia
Renal Dialysis
Pathologic Constriction
Gold
Fistula
Angiography
Therapeutics
Morbidity
Biopsy
Mortality
Research

Keywords

  • angioplasty
  • Arteriovenous fistula (AVF)
  • hemodialysis
  • intimal hyperplasia
  • primary failure
  • stenosis
  • vascular access dysfunction
  • vascular remodeling

ASJC Scopus subject areas

  • Nephrology

Cite this

Dialysis Arteriovenous Fistula Failure and Angioplasty : Intimal Hyperplasia and Other Causes of Access Failure. / Duque, Juan C.; Tabbara, Marwan; Martinez, Laisel; Cardona, Jose; Vazquez-Padron, Roberto I; Salman, Loay.

In: American Journal of Kidney Diseases, Vol. 69, No. 1, 01.01.2017, p. 147-151.

Research output: Contribution to journalArticle

@article{f7057387d2a44cccafe5f533232f8337,
title = "Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure",
abstract = "The arteriovenous fistula (AVF) is the preferred hemodialysis access type because it has better patency rates and fewer complications than other access types. However, primary failure remains a common problem impeding AVF maturation and adding to patients’ morbidity and mortality. Juxta-anastomotic (or inflow) stenosis is the most common reason leading to primary failure, and percutaneous transluminal angioplasty continues to be the gold-standard treatment with excellent success rates. Intimal hyperplasia (IH) has been traditionally blamed as the main pathophysiologic culprit, but new evidence raises doubts regarding the contribution of IH alone to primary failure. We report a 64-year-old man with a 2-stage brachiobasilic AVF that was complicated by failure 4 months after creation. An angiogram showed multiple juxta-anastomotic and midfistula stenotic lesions. Percutaneous transluminal angioplasty was successful in assisting maturation and subsequently cannulating the AVF for hemodialysis treatment. We failed to identify the underlying cause of stenosis because biopsy specimens from fistula tissue obtained at the time of transposition revealed no occlusive IH. This case emphasizes the need for additional research on factors contributing to AVF failure besides IH and highlights the need for more therapeutic options to reduce AVF failure rate.",
keywords = "angioplasty, Arteriovenous fistula (AVF), hemodialysis, intimal hyperplasia, primary failure, stenosis, vascular access dysfunction, vascular remodeling",
author = "Duque, {Juan C.} and Marwan Tabbara and Laisel Martinez and Jose Cardona and Vazquez-Padron, {Roberto I} and Loay Salman",
year = "2017",
month = "1",
day = "1",
doi = "10.1053/j.ajkd.2016.08.025",
language = "English (US)",
volume = "69",
pages = "147--151",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Dialysis Arteriovenous Fistula Failure and Angioplasty

T2 - Intimal Hyperplasia and Other Causes of Access Failure

AU - Duque, Juan C.

AU - Tabbara, Marwan

AU - Martinez, Laisel

AU - Cardona, Jose

AU - Vazquez-Padron, Roberto I

AU - Salman, Loay

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The arteriovenous fistula (AVF) is the preferred hemodialysis access type because it has better patency rates and fewer complications than other access types. However, primary failure remains a common problem impeding AVF maturation and adding to patients’ morbidity and mortality. Juxta-anastomotic (or inflow) stenosis is the most common reason leading to primary failure, and percutaneous transluminal angioplasty continues to be the gold-standard treatment with excellent success rates. Intimal hyperplasia (IH) has been traditionally blamed as the main pathophysiologic culprit, but new evidence raises doubts regarding the contribution of IH alone to primary failure. We report a 64-year-old man with a 2-stage brachiobasilic AVF that was complicated by failure 4 months after creation. An angiogram showed multiple juxta-anastomotic and midfistula stenotic lesions. Percutaneous transluminal angioplasty was successful in assisting maturation and subsequently cannulating the AVF for hemodialysis treatment. We failed to identify the underlying cause of stenosis because biopsy specimens from fistula tissue obtained at the time of transposition revealed no occlusive IH. This case emphasizes the need for additional research on factors contributing to AVF failure besides IH and highlights the need for more therapeutic options to reduce AVF failure rate.

AB - The arteriovenous fistula (AVF) is the preferred hemodialysis access type because it has better patency rates and fewer complications than other access types. However, primary failure remains a common problem impeding AVF maturation and adding to patients’ morbidity and mortality. Juxta-anastomotic (or inflow) stenosis is the most common reason leading to primary failure, and percutaneous transluminal angioplasty continues to be the gold-standard treatment with excellent success rates. Intimal hyperplasia (IH) has been traditionally blamed as the main pathophysiologic culprit, but new evidence raises doubts regarding the contribution of IH alone to primary failure. We report a 64-year-old man with a 2-stage brachiobasilic AVF that was complicated by failure 4 months after creation. An angiogram showed multiple juxta-anastomotic and midfistula stenotic lesions. Percutaneous transluminal angioplasty was successful in assisting maturation and subsequently cannulating the AVF for hemodialysis treatment. We failed to identify the underlying cause of stenosis because biopsy specimens from fistula tissue obtained at the time of transposition revealed no occlusive IH. This case emphasizes the need for additional research on factors contributing to AVF failure besides IH and highlights the need for more therapeutic options to reduce AVF failure rate.

KW - angioplasty

KW - Arteriovenous fistula (AVF)

KW - hemodialysis

KW - intimal hyperplasia

KW - primary failure

KW - stenosis

KW - vascular access dysfunction

KW - vascular remodeling

UR - http://www.scopus.com/inward/record.url?scp=85006004223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006004223&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2016.08.025

DO - 10.1053/j.ajkd.2016.08.025

M3 - Article

C2 - 28084215

AN - SCOPUS:85006004223

VL - 69

SP - 147

EP - 151

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -